* Alimera Sciences Inc ALIM.OQ reported a quarterly
adjusted
loss of 45 cents per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 55 cents per share.
* Revenue fell 32.7% to $14.60 million from a year ago;
analysts
expected $13.14 million.
* Alimera Sciences Inc's reported EPS for the quarter was a
loss
of 45 cents.
* The mean earnings estimate of analysts had risen by
about 8.5%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Alimera Sciences Inc shares had fallen by 5.9% this
quarter and
gained 0.4% so far this year.
* The company reported a quarterly loss of $3.12 million.
* Wall Street's median 12-month price target for Alimera
Sciences
Inc is $11.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data July 27
at 01:32 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.55 -0.45 Beat
Mar. 31 2022 -0.69 -0.85 Missed
Dec. 31 2021 -0.42 -0.59 Missed
Sep. 30 2021 -0.52 -0.60 Missed